Status: Recruiting
Golidocitinib Combined With Selinexor for CAEBVD
This study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
Participants needed: 28
Trial details
Phase: Phase 2, Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Beijing Friendship HospitalUpdated: Jan 27, 2026Locations: 1
Eligibility criteria
CAEBVD diagnosed in accordance with the Consensus on the Diagnosis and Treatment... [+7]
Evidence of EBV-associated hematological diseases or malignancies, such as hemop... [+11]